Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
10 2021
Historique:
received: 15 01 2021
revised: 27 07 2021
accepted: 21 08 2021
pubmed: 31 8 2021
medline: 31 12 2021
entrez: 30 8 2021
Statut: ppublish

Résumé

We investigated the relationship between RBE-weighted dose (DRBE) calculated with constant (cRBE) and variable RBE (vRBE), dose-averaged linear energy transfer (LETd) and the risk of radiographic changes in skull base patients treated with protons. Clinical treatment plans of 45 patients were recalculated with Monte Carlo tool FRED. Radiographic changes (i.e. edema and/or necrosis) were identified by MRI. Dosimetric parameters for cRBE and vRBE were computed. Biological margin extension and voxel-based analysis were employed looking for association of DRBE(vRBE) and LETd with brain edema and/or necrosis. When using vRBE, Dmax in the brain was above the highest dose limits for 38% of patients, while such limit was never exceeded assuming cRBE. Similar values of Dmax were observed in necrotic regions, brain and temporal lobes. Most of the brain necrosis was in proximity to the PTV. The voxel-based analysis did not show evidence of an association with high LETd values. When looking at standard dosimetric parameters, the higher dose associated with vRBE seems to be responsible for an enhanced risk of radiographic changes. However, as revealed by a voxel-based analysis, the large inter-patient variability hinders the identification of a clear effect for high LETd.

Identifiants

pubmed: 34461183
pii: S0167-8140(21)06709-8
doi: 10.1016/j.radonc.2021.08.015
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-149

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Magdalena Garbacz (M)

Institute of Nuclear Physics Polish Academy of Sciences, 31342 Krakow, Poland. Electronic address: magdalena.garbacz@ifj.edu.pl.

Francesco Giuseppe Cordoni (FG)

University of Verona, Department of Computer Science, Verona, Italy; Trento Institute for Fundamental Physics and Applications, TIFPA-INFN, Trento, Italy.

Marco Durante (M)

GSI Helmholtzzentrum fur Schwerionenforschung, Darmstadt, Germany; The Technical University of Darmstadt, Germany.

Jan Gajewski (J)

Institute of Nuclear Physics Polish Academy of Sciences, 31342 Krakow, Poland.

Kamil Kisielewicz (K)

National Oncology Institute, National Research Institute, Krakow Branch, Krakow, Poland.

Nils Krah (N)

University of Lyon, CREATIS, CNRS UMR5220, Inserm U1044, INSA-Lyon, Université Lyon 1, Centre Léon Bérard, France; University of Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3, IP2I Lyon, UMR 5822, Villeurbanne, France.

Renata Kopeć (R)

Institute of Nuclear Physics Polish Academy of Sciences, 31342 Krakow, Poland.

Paweł Olko (P)

Institute of Nuclear Physics Polish Academy of Sciences, 31342 Krakow, Poland.

Vincenzo Patera (V)

INFN - Section of Rome, Italy; Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Italy.

Ilaria Rinaldi (I)

Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Marzena Rydygier (M)

Institute of Nuclear Physics Polish Academy of Sciences, 31342 Krakow, Poland.

Angelo Schiavi (A)

Department of Basic and Applied Sciences for Engineering, Sapienza University of Rome, Italy.

Emanuele Scifoni (E)

Trento Institute for Fundamental Physics and Applications, TIFPA-INFN, Trento, Italy.

Tomasz Skóra (T)

National Oncology Institute, National Research Institute, Krakow Branch, Krakow, Poland.

Francesco Tommasino (F)

Trento Institute for Fundamental Physics and Applications, TIFPA-INFN, Trento, Italy; Department of Physics, University of Trento, Trento, Italy.

Antoni Rucinski (A)

Institute of Nuclear Physics Polish Academy of Sciences, 31342 Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH